SEER
Seer, Inc.
Price Chart
Latest Quote
$1.74
+0.02 (+1.16%)
Current Price
| Previous Close | $1.72 |
| Open | $1.72 |
| Day High | $1.74 |
| Day Low | $1.71 |
| Volume | 83,136 |
Stock Information
| Shares Outstanding | 54.98M |
| Total Debt | $23.03M |
| Cash Equivalents | $166.67M |
| Revenue | $15.17M |
| Net Income | $-70.49M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $95.67M |
| EPS (TTM) | $-1.25 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $-47.98M |
| Sales | $15.17M |
| Income | $-70.49M |
| Book/sh | $4.61 |
| Cash/sh | $3.03 |
| Employees | 124 |
Financial Ratios
| Quick Ratio | 16.69 |
| Current Ratio | 17.73 |
| Debt/Eq | 9.54 |
Returns & Margins
| ROA | -15.04% |
| ROE | -25.52% |
| Gross Margin | 48.70% |
| Operating Margin | -617.83% |
Ownership
| Insider Ownership | 14.47% |
| Institutional Ownership | 51.16% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -1.78 |
| P/S | 6.31 |
| P/B | 0.38 |
Analyst Data
| Recommendation | none |
| Target Price | $4.00 |
Technical Indicators
| SMA20 | $1.79 |
| SMA50 | $1.84 |
| SMA200 | $1.93 |
| RSI | 25.93 |
| ATR | 0.0461 |
| Shares Float | 40.11M |
| Short Float | 0.60% |
| Short Ratio | 0.82 |
| Volatility | 1.59 |
| Rel Volume | 0.64 |
Performance History
| Week | +2.35% |
| Month | +3.57% |
| Quarter | +0.87% |
| 6 Months | -5.43% |
| YTD | -4.40% |
| Year | -11.22% |
| 3 Years | -62.09% |
| 5 Years | -94.75% |
| 10 Years | -96.92% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $1.74 | 102,100 |
| 2026-06-17 | $1.72 | 65,900 |
| 2026-06-16 | $1.71 | 141,500 |
| 2026-06-15 | $1.71 | 106,700 |
| 2026-06-12 | $1.72 | 96,300 |
| 2026-06-11 | $1.70 | 155,500 |
| 2026-06-10 | $1.69 | 78,700 |
| 2026-06-09 | $1.69 | 436,700 |
| 2026-06-08 | $1.79 | 171,000 |
| 2026-06-05 | $1.79 | 76,300 |
| 2026-06-04 | $1.85 | 45,100 |
| 2026-06-03 | $1.86 | 56,600 |
| 2026-06-02 | $1.87 | 79,300 |
| 2026-06-01 | $1.88 | 115,700 |
| 2026-05-29 | $1.87 | 215,300 |
| 2026-05-28 | $1.93 | 113,000 |
| 2026-05-27 | $1.89 | 135,000 |
| 2026-05-26 | $1.87 | 235,000 |
| 2026-05-22 | $1.79 | 559,400 |
| 2026-05-21 | $1.77 | 215,400 |
| 2026-05-20 | $1.68 | 367,900 |
| 2026-05-19 | $1.68 | 454,700 |
About Seer, Inc.
Seer, Inc., a life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa. The company offers Proteograph Product Suite, an integrated solution, which includes proprietary engineered nanoparticles, consumables, automation instrumentation, and data analysis software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company also offers Proteograph ONE, a third-generation assay; Proteograph DIRECT, which provides an automated approach for direct digestion of samples for bottom-up LC-MS proteomic analysis; and Proteograph Analysis Suite, a data analytics software suite designed to support quality control, data management, and interpretation of Proteograph output which is currently offered as a cloud-based solution. It markets and sells its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.
đ° Latest News
Seer, Inc. Q1 2026 Earnings Call Summary
Moby âĸ 2026-05-14T12:30:00Z
Seer Inc (SEER) Q1 2026 Earnings Call Highlights: Navigating Revenue Decline Amid Competitive ...
GuruFocus.com âĸ 2026-05-14T05:01:51ZSeer Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-14T04:12:30Z
Full Transcript: Seer Q1 2026 Earnings Call
Benzinga âĸ 2026-05-13T21:31:04Z
How Seer (SEER) Is Rewriting Its Story With New Targets And Activist Pressure
Simply Wall St. âĸ 2026-05-06T23:13:58Z
Uncovering Opportunities: Penny Stocks To Watch In April 2026
Simply Wall St. âĸ 2026-04-17T18:05:06Z
Sector Update: Health Care Stocks Advance Late Afternoon
MT Newswires âĸ 2026-04-13T19:53:20ZSector Update: Health Care Stocks Softer Monday Afternoon
MT Newswires âĸ 2026-04-13T17:36:53ZThermo Fisher Stock May Benefit Following Collaboration With PRECISE
Zacks âĸ 2026-04-10T14:04:00Z
Bullish Seer Insiders Loaded Up On US$5.29m Of Stock
Simply Wall St. âĸ 2026-03-29T12:30:34Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $8,113,000 | $7,115,000 | $8,155,000 | $8,400,000 |
| Cost Of Revenue | $8,113,000 | $7,115,000 | $8,155,000 | $8,400,000 |
| Total Revenue | $16,119,000 | $13,947,000 | $15,182,000 | $14,685,000 |
| Operating Revenue | $16,119,000 | $13,947,000 | $15,182,000 | $14,685,000 |
| Expenses | ||||
| Total Expenses | $94,111,000 | $114,048,000 | $118,645,000 | $111,920,000 |
| Other Income Expense | $-6,929,000 | $-3,066,000 | $-578,000 | $-333,000 |
| Other Non Operating Income Expenses | $-1,010,000 | $-417,000 | $-578,000 | $-333,000 |
| Net Non Operating Interest Income Expense | $11,522,000 | $16,666,000 | $17,764,000 | $4,602,000 |
| Operating Expense | $85,998,000 | $106,933,000 | $110,490,000 | $103,520,000 |
| Other Operating Expenses | $-459,000 | $-223,000 | $-1,479,000 | $-808,000 |
| Interest Expense | - | - | - | $0 |
| Interest Expense Non Operating | - | - | - | $0 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-73,600,000 | $-86,599,000 | $-86,277,000 | $-92,966,000 |
| Net Interest Income | $11,522,000 | $16,666,000 | $17,764,000 | $4,602,000 |
| Interest Income | $11,522,000 | $16,666,000 | $17,764,000 | $4,602,000 |
| Normalized Income | $-73,600,000 | $-86,599,000 | $-86,277,000 | $-92,966,000 |
| Net Income From Continuing And Discontinued Operation | $-73,600,000 | $-86,599,000 | $-86,277,000 | $-92,966,000 |
| Total Operating Income As Reported | $-77,992,000 | $-100,101,000 | $-103,463,000 | $-97,235,000 |
| Net Income Common Stockholders | $-73,600,000 | $-86,599,000 | $-86,277,000 | $-92,966,000 |
| Net Income | $-73,600,000 | $-86,599,000 | $-86,277,000 | $-92,966,000 |
| Net Income Including Noncontrolling Interests | $-73,600,000 | $-86,599,000 | $-86,277,000 | $-92,966,000 |
| Net Income Continuous Operations | $-73,600,000 | $-86,599,000 | $-86,277,000 | $-92,966,000 |
| Pretax Income | $-73,399,000 | $-86,501,000 | $-86,277,000 | $-92,966,000 |
| Earnings From Equity Interest | $-5,919,000 | $-2,649,000 | $0 | - |
| Interest Income Non Operating | $11,522,000 | $16,666,000 | $17,764,000 | $4,602,000 |
| Operating Income | $-77,992,000 | $-100,101,000 | $-103,463,000 | $-97,235,000 |
| Gross Profit | $8,006,000 | $6,832,000 | $7,027,000 | $6,285,000 |
| Per Share | ||||
| Diluted EPS | $-1.28 | $-1.39 | $-1.35 | $-1.49 |
| Basic EPS | $-1.28 | $-1.39 | $-1.35 | $-1.49 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-71,888,000 | $-93,925,000 | $-97,885,000 | $-93,293,000 |
| Reconciled Depreciation | $6,104,000 | $6,176,000 | $5,578,000 | $3,942,000 |
| EBITDA (Bullshit earnings) | $-71,888,000 | $-93,925,000 | $-97,885,000 | $-93,293,000 |
| EBIT | $-77,992,000 | $-100,101,000 | $-103,463,000 | $-97,235,000 |
| Diluted Average Shares | $57,447,580 | $62,348,012 | $63,850,490 | $62,433,613 |
| Basic Average Shares | $57,447,580 | $62,348,012 | $63,850,490 | $62,433,613 |
| Diluted NI Availto Com Stockholders | $-73,600,000 | $-86,599,000 | $-86,277,000 | $-92,966,000 |
| Tax Provision | $201,000 | $98,000 | $0 | - |
| Research And Development | $43,874,000 | $50,585,000 | $53,019,000 | $45,797,000 |
| Selling General And Administration | $42,583,000 | $56,571,000 | $58,950,000 | $58,531,000 |
Fetched: 2026-06-18
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $259,307,000 | $327,569,000 | $396,904,000 | $446,993,000 |
| Total Assets | $296,083,000 | $366,597,000 | $436,269,000 | $487,929,000 |
| Total Non Current Assets | $94,549,000 | $113,274,000 | $105,756,000 | $52,947,000 |
| Other Non Current Assets | $4,621,000 | $8,805,000 | $1,528,000 | $1,379,000 |
| Investmentin Financial Assets | $54,686,000 | $63,103,000 | $56,858,000 | $5,157,000 |
| Current Assets | $201,534,000 | $253,323,000 | $330,513,000 | $434,982,000 |
| Other Current Assets | $1,890,000 | $3,248,000 | $3,082,000 | $2,098,000 |
| Inventory | $7,795,000 | $7,436,000 | $4,491,000 | $4,627,000 |
| Receivables | $5,952,000 | $6,229,000 | $6,716,000 | $7,018,000 |
| Other Receivables | $1,370,000 | $1,853,000 | $1,326,000 | $899,000 |
| Accounts Receivable | $4,282,000 | $3,997,000 | $4,831,000 | $4,315,000 |
| Allowance For Doubtful Accounts Receivable | $-1,000 | $-1,000 | $-4,000 | - |
| Gross Accounts Receivable | $4,283,000 | $3,999,000 | $4,835,000 | - |
| Cash Cash Equivalents And Short Term Investments | $185,897,000 | $236,410,000 | $316,224,000 | $421,239,000 |
| Cash And Cash Equivalents | $47,285,000 | $40,753,000 | $32,499,000 | $53,208,000 |
| Cash Equivalents | $47,285,000 | $40,753,000 | $32,499,000 | $53,208,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $23,652,000 | $25,964,000 | $28,259,000 | $29,874,000 |
| Long Term Debt And Capital Lease Obligation | $21,077,000 | $23,652,000 | $25,964,000 | $28,032,000 |
| Current Debt And Capital Lease Obligation | $2,575,000 | $2,312,000 | $2,295,000 | $1,842,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $36,776,000 | $39,028,000 | $39,365,000 | $40,936,000 |
| Total Non Current Liabilities Net Minority Interest | $21,085,000 | $23,700,000 | $26,143,000 | $28,352,000 |
| Other Non Current Liabilities | $8,000 | $48,000 | $179,000 | $320,000 |
| Current Liabilities | $15,691,000 | $15,328,000 | $13,222,000 | $12,584,000 |
| Other Current Liabilities | $29,000 | $50,000 | $139,000 | $207,000 |
| Current Deferred Liabilities | $341,000 | $408,000 | $206,000 | $133,000 |
| Payables And Accrued Expenses | $7,149,000 | $6,586,000 | $4,459,000 | $4,263,000 |
| Payables | $6,246,000 | $5,092,000 | $1,871,000 | $2,439,000 |
| Total Tax Payable | $635,000 | $471,000 | $501,000 | $335,000 |
| Accounts Payable | $5,611,000 | $4,621,000 | $1,370,000 | $2,104,000 |
| Non Current Deferred Liabilities | - | - | - | - |
| Equity | ||||
| Common Stock Equity | $259,307,000 | $327,569,000 | $396,904,000 | $446,993,000 |
| Total Equity Gross Minority Interest | $259,307,000 | $327,569,000 | $396,904,000 | $446,993,000 |
| Stockholders Equity | $259,307,000 | $327,569,000 | $396,904,000 | $446,993,000 |
| Gains Losses Not Affecting Retained Earnings | $459,000 | $136,000 | $-192,000 | $-1,251,000 |
| Other Equity Adjustments | $459,000 | $136,000 | $-192,000 | $-1,251,000 |
| Retained Earnings | $-465,972,000 | $-392,372,000 | $-305,773,000 | $-219,496,000 |
| Other | ||||
| Ordinary Shares Number | $56,219,599 | $59,128,092 | $64,298,676 | $63,411,046 |
| Share Issued | $56,219,599 | $59,128,092 | $64,298,676 | $63,411,046 |
| Tangible Book Value | $259,307,000 | $327,569,000 | $396,904,000 | $446,993,000 |
| Invested Capital | $259,307,000 | $327,569,000 | $396,904,000 | $446,993,000 |
| Working Capital | $185,843,000 | $237,995,000 | $317,291,000 | $422,398,000 |
| Capital Lease Obligations | $23,652,000 | $25,964,000 | $28,259,000 | $29,874,000 |
| Total Capitalization | $259,307,000 | $327,569,000 | $396,904,000 | $446,993,000 |
| Additional Paid In Capital | $724,819,000 | $719,804,000 | $702,868,000 | $667,739,000 |
| Capital Stock | $1,000 | $1,000 | $1,000 | $1,000 |
| Common Stock | $1,000 | $1,000 | $1,000 | $1,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $21,077,000 | $23,652,000 | $25,964,000 | $28,032,000 |
| Current Deferred Revenue | $341,000 | $408,000 | $206,000 | $133,000 |
| Current Capital Lease Obligation | $2,575,000 | $2,312,000 | $2,295,000 | $1,842,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $5,597,000 | $5,972,000 | $6,123,000 | $6,139,000 |
| Current Accrued Expenses | $903,000 | $1,494,000 | $2,588,000 | $1,824,000 |
| Investments And Advances | $54,686,000 | $63,103,000 | $56,858,000 | $5,157,000 |
| Available For Sale Securities | $54,686,000 | $63,103,000 | $56,858,000 | $5,157,000 |
| Net PPE | $35,242,000 | $41,366,000 | $47,370,000 | $46,411,000 |
| Accumulated Depreciation | $-19,426,000 | $-16,814,000 | $-12,539,000 | $-7,821,000 |
| Gross PPE | $54,668,000 | $58,180,000 | $59,909,000 | $54,232,000 |
| Leases | $3,626,000 | $3,577,000 | $3,520,000 | $3,375,000 |
| Construction In Progress | $127,000 | $424,000 | $1,109,000 | $1,281,000 |
| Other Properties | $46,876,000 | $51,514,000 | $53,740,000 | $48,125,000 |
| Machinery Furniture Equipment | $4,039,000 | $2,665,000 | $1,540,000 | $1,451,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $4,084,000 | $4,196,000 | $2,210,000 | $2,227,000 |
| Work In Process | $46,000 | $76,000 | $163,000 | $271,000 |
| Raw Materials | $3,665,000 | $3,164,000 | $2,118,000 | $2,129,000 |
| Duefrom Related Parties Current | $300,000 | $379,000 | $559,000 | $1,804,000 |
| Other Short Term Investments | $138,612,000 | $195,657,000 | $283,725,000 | $368,031,000 |
Fetched: 2026-06-18
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-46,245,000 | $-49,693,000 | $-66,374,000 | $-71,045,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-44,448,000 | $-46,109,000 | $-59,065,000 | $-60,780,000 |
| Cash Flow From Continuing Operating Activities | $-44,448,000 | $-46,109,000 | $-59,065,000 | $-60,780,000 |
| Operating Gains Losses | $6,933,000 | $2,928,000 | $399,000 | $332,000 |
| Investing Activities | ||||
| Capital Expenditure | $-1,797,000 | $-3,584,000 | $-7,309,000 | $-10,265,000 |
| Investing Cash Flow | $61,548,000 | $65,858,000 | $37,904,000 | $-122,718,000 |
| Cash Flow From Continuing Investing Activities | $61,548,000 | $65,858,000 | $37,904,000 | $-122,718,000 |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-10,199,000 | $-11,816,000 | $-13,000 | $-20,000 |
| Financing Cash Flow | $-10,568,000 | $-11,495,000 | $452,000 | $3,893,000 |
| Cash Flow From Continuing Financing Activities | $-10,568,000 | $-11,495,000 | $452,000 | $3,893,000 |
| Net Other Financing Charges | $-827,000 | - | - | - |
| Net Common Stock Issuance | $-10,199,000 | $-11,816,000 | $-13,000 | $-20,000 |
| Issuance Of Capital Stock | - | - | - | $0 |
| Common Stock Issuance | - | - | - | $0 |
| Net Preferred Stock Issuance | - | - | - | - |
| Preferred Stock Issuance | - | - | - | - |
| Other | ||||
| Income Tax Paid Supplemental Data | $182,000 | $154,000 | $0 | $232,000 |
| End Cash Position | $47,809,000 | $41,277,000 | $33,023,000 | $53,732,000 |
| Beginning Cash Position | $41,277,000 | $33,023,000 | $53,732,000 | $233,337,000 |
| Changes In Cash | $6,532,000 | $8,254,000 | $-20,709,000 | $-179,605,000 |
| Proceeds From Stock Option Exercised | $458,000 | $321,000 | $465,000 | $3,913,000 |
| Common Stock Payments | $-10,199,000 | $-11,816,000 | $-13,000 | $-20,000 |
| Net Investment Purchase And Sale | $62,699,000 | $69,099,000 | $45,213,000 | $-112,623,000 |
| Sale Of Investment | $237,814,000 | $342,025,000 | $448,305,000 | $253,645,000 |
| Purchase Of Investment | $-175,115,000 | $-272,926,000 | $-403,092,000 | $-366,268,000 |
| Net PPE Purchase And Sale | $-1,151,000 | $-3,241,000 | $-7,309,000 | $-10,095,000 |
| Sale Of PPE | $646,000 | $343,000 | $0 | $170,000 |
| Purchase Of PPE | $-1,797,000 | $-3,584,000 | $-7,309,000 | $-10,265,000 |
| Change In Working Capital | $-579,000 | $-144,000 | $-2,724,000 | $-7,090,000 |
| Change In Other Working Capital | $-67,000 | $202,000 | $73,000 | $-243,000 |
| Change In Payables And Accrued Expense | $542,000 | $1,927,000 | $162,000 | $-1,302,000 |
| Change In Accrued Expense | $-520,000 | $-1,428,000 | $1,149,000 | $251,000 |
| Change In Payable | $1,062,000 | $3,355,000 | $-987,000 | $-1,553,000 |
| Change In Account Payable | $1,062,000 | $3,355,000 | $-987,000 | $-1,553,000 |
| Change In Prepaid Assets | $1,570,000 | $-92,000 | $-1,313,000 | $-1,081,000 |
| Change In Inventory | $-2,901,000 | $-2,668,000 | $-1,948,000 | $-1,590,000 |
| Change In Receivables | $277,000 | $487,000 | $302,000 | $-2,874,000 |
| Changes In Account Receivables | $277,000 | $487,000 | $302,000 | $-2,874,000 |
| Other Non Cash Items | $-9,000 | $91,000 | $211,000 | $1,655,000 |
| Stock Based Compensation | $15,414,000 | $28,207,000 | $34,424,000 | $33,673,000 |
| Provisionand Write Offof Assets | $148,000 | $179,000 | $872,000 | $507,000 |
| Amortization Of Securities | $1,141,000 | $3,053,000 | $-11,548,000 | $-833,000 |
| Depreciation Amortization Depletion | $6,104,000 | $6,176,000 | $5,578,000 | $3,942,000 |
| Depreciation And Amortization | $6,104,000 | $6,176,000 | $5,578,000 | $3,942,000 |
| Earnings Losses From Equity Investments | $5,919,000 | $2,649,000 | $0 | - |
| Gain Loss On Sale Of PPE | $1,014,000 | $279,000 | $399,000 | $332,000 |
| Net Income From Continuing Operations | $-73,600,000 | $-86,599,000 | $-86,277,000 | $-92,966,000 |
| Change In Other Current Liabilities | - | - | - | $-93,000 |
| Change In Other Current Assets | - | - | - | $-354,000 |
| Net Business Purchase And Sale | - | - | - | - |
| Purchase Of Business | - | - | - | - |
Fetched: 2026-06-18